Crescent Biopharma CBIO
NASDAQ CBIO
$13.17 +0.10 (+0.77%)
At close: Oct 21, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Non Operating Income (2013 - 2026)

Updated

Crescent Biopharma's Non Operating Income was -$3.3 million in Q2 2026, compared with $760,000 a year earlier.

Analysis

Crescent Biopharma (CBIO) Non Operating Income (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Crescent Biopharma's Non Operating Income was -$2.84 million through Jun 30, 2026; for FY2025, it came in at -$690,000.

  • In earlier years, Non Operating Income was $2.16 million in FY2024 (-9.1%) and $2.38 million in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Non Operating Income in data going back to Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 387.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Crescent Biopharma 401.19 Mn -306.10 Mn - -3.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.30 Mn
Mar 31, 2026 -1.45 Mn
Jun 30, 2025 760,000.00
Mar 31, 2025 1.15 Mn
Dec 31, 2024 110,107.00
Sep 30, 2024 1.41 Mn
Dec 31, 2023 512,194.00
Sep 30, 2023 610,978.00
Mar 31, 2014 4,773.00
Mar 31, 2013 965.00
API Access

Crescent Biopharma Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CBIO&period=max&api_key=YOUR_API_KEY